Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Documentation in Long-Term and Home Healthcare Setting01:29

Documentation in Long-Term and Home Healthcare Setting

Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tracking Extended-Spectrum β-Lactamase-Producing <i>Escherichia coli</i> Across Human Communities and Dairy Ecosystems: A One Health Investigation.

Antibiotics (Basel, Switzerland)·2026
Same author

Seasonal and spatial dynamics of <i>Enterococcus</i> and antimicrobial resistance in a one health dairy ecosystem in Western Canada.

One health (Amsterdam, Netherlands)·2026
Same author

Phylogenomic and functional insights into <i>Staphylococcus shinii</i> from blueberry production environments: intra-species structure, probiotic traits and antimicrobial resistance.

Microbial genomics·2026
Same author

A One Health comparative genomic assessment of antimicrobial-resistant <i>Escherichia coli</i> in dairy farms in western Canada.

Applied and environmental microbiology·2026
Same author

Genomic characterization of pathotype diversity and drug resistance among generic <i>Escherichia coli</i> isolated from broiler chickens in Canada.

Canadian journal of microbiology·2025
Same author

Chronic Kidney Disease and Military Service in US Adults, 1999-2018.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2024
Same journal

Intracardiac Vascular Access for Hemodialysis Despite Associated Ascending Aortic Aneurysm.

Seminars in dialysis·2026
Same journal

Measures of Equivalent Hemodialysis Urea Clearance and Their Proposed Utility for Monitoring Adequacy.

Seminars in dialysis·2026
Same journal

Risk of Serious Adverse Events and Death With Low-Dose Methotrexate Versus Hydroxychloroquine in Adults Receiving Dialysis.

Seminars in dialysis·2026
Same journal

Severe Hematoma Following Initial Arteriovenous Fistula Puncture in a Hemodialysis Patient, Emphasizing Thoracic Outlet Syndrome: A Case Report.

Seminars in dialysis·2026
Same journal

Phosphate Kinetic Modeling in Patients Treated With Hemodialysis or Hemodiafiltration: A Prospective, Multicenter, Cross-Sectional Study.

Seminars in dialysis·2026
Same journal

Impact of Expanded Hemodialysis on Inflammation and Iron Metabolism in Chronic Hemodialysis Patients.

Seminars in dialysis·2026
See all related articles

Related Experiment Video

Updated: Jun 4, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Vascular access for HD: aligning payment with quality.

Chester A Amedia1, W Kline Bolton, Trelles Cordray

  • 1Health Policy Workgroup, Fistula First Breakthrough Initiative, Northeastern Ohio Universities College of Medicine, Rootstown, Ohio 44512, USA. camedia@celvida.com

Seminars in Dialysis
|February 23, 2011
PubMed
Summary
This summary is machine-generated.

The Fistula First Breakthrough Initiative (FFBI) promotes arteriovenous fistula creation for end-stage renal disease (ESRD) patients. Nephrologists must lead fistula creation and reduce catheter use for successful outcomes and healthcare savings.

Related Experiment Videos

Last Updated: Jun 4, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Area of Science:

  • Nephrology
  • Health Policy
  • Healthcare Economics

Background:

  • The Fistula First Breakthrough Initiative (FFBI) has increased awareness of the benefits of arteriovenous fistula creation for end-stage renal disease (ESRD) patients.
  • The FFBI Health Policy Workgroup examines policy and economic factors influencing fistula creation.

Purpose of the Study:

  • To review clinical activities and economic impacts of fistula creation and catheter reduction.
  • To identify and address major and less recognized barriers to achieving FFBI goals.

Main Methods:

  • Review of renal community clinical activities and successes.
  • Analysis of policy and economic issues related to fistula creation.
  • Identification of obstacles and existing solutions.
  • Discussion of less recognized barriers and proposed solutions.

Main Results:

  • Fistula creation and central venous catheter reduction have significant economic benefits for the healthcare system.
  • Major and less recognized obstacles to FFBI goals have been identified.
  • Existing tools and efforts to overcome barriers are outlined.

Conclusions:

  • Nephrologists must take a leadership role in driving fistula creation.
  • Reducing central venous catheter use is crucial for programmatic success.
  • Implementing proposed solutions can help achieve FFBI objectives.